Together, these results reveal that the presence of poorly immunogenic tumor homografts in mice leads to elevated CD5 on T cells in lymph nodes, similar to the increase in CD5 seen after ex vivo stimulation of the TCR/CD3 complex on CD8+ T cells. This evidence concerns the gene CD5 and neoplasm.